Tie2 ligands angiopoietin-1 and angiopoietin-2 are coexpressed with vascular endothelial cell growth factor in growing human bone
Authors:
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Expression of Angiopoietin-1, Angiopoietin-2, and the Tie-2 Receptor Tyrosine Kinase during Mouse Kidney MaturationJournal of the American Society of Nephrology, 1999
- Cartilage to bone—Angiogenesis leads the wayNature Medicine, 1999
- VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formationNature Medicine, 1999
- Immunolocalisation of vascular endothelial growth factor (VEGF) in human neonatal growth plate cartilageJournal of Anatomy, 1999
- Angiopoietin‐1 is an apoptosis survival factor for endothelial cellsFEBS Letters, 1999
- Preclinical Safety Evaluation of rhuMAbVEGF, an Antiangiogenic Humanized Monoclonal AntibodyToxicologic Pathology, 1999
- Isolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression CloningCell, 1996
- Fluctuation of mineral apposition rate at individual bone-remodeling sites in human iliac cancellous bone: Independent correlations with osteoid width and osteoblastic alkaline phosphatase activityJournal of Bone and Mineral Research, 1994
- Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo.Genes & Development, 1994
- Expression of Vascular Endothelial Growth Factor in Capillary HemangioblastomaBiochemical and Biophysical Research Communications, 1993